Ambu® Laryngeal Mask as an Intubation Conduit

NCT00272194 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2016-03-23

No results posted yet for this study

Summary

The purpose of this study is to determine if the Ambu Laryngeal Mask can be used as an intubation conduit for endotracheal intubation.

Conditions

  • Intubation, Endotracheal

Interventions

DEVICE

Ambu Laryngeal Mask

DEVICE

Aintree Exchange Catheter

DEVICE

Laryngeal Mask Airway

Sponsors & Collaborators

  • Ambu A/S

    collaborator INDUSTRY
  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Carin A. Hagberg, M.D. · The University of Texas Medical School at Houston

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00272194 on ClinicalTrials.gov